Wordsworth P
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, U.K.
Eur J Immunogenet. 1991 Feb-Apr;18(1-2):139-46. doi: 10.1111/j.1744-313x.1991.tb00013.x.
Associations between a large number of diseases and markers within the major histocompatibility complex (MHC) have been described. In particular, susceptibility to several autoimmune disorders, including type I diabetes mellitus and rheumatoid arthritis, is linked to genes within the MHC and strong population associations are demonstrable between certain HLA class II alleles and these conditions. Genetic mapping of HLA susceptibility loci has traditionally relied on the use of phenotypic markers defined by alloantisera, cellular typing reagents and biochemical analysis of histocompatibility antigens. Polymerase chain reaction sequence-specific oligonucleotide (PCR-SSO) typing combines the ability to define the finest of HLA specificities, by analysis of the corresponding DNA sequences, with the possibility of study large populations of normal and affected individuals. The applications of this technology to characterizing precisely the MHC loci associated with susceptibility to autoimmune diseases such as rheumatoid arthritis, type I diabetes mellitus, coeliac disease and pemphigus vulgaris are reviewed here.
大量疾病与主要组织相容性复合体(MHC)内的标志物之间的关联已被描述。特别是,对包括I型糖尿病和类风湿性关节炎在内的几种自身免疫性疾病的易感性与MHC内的基因相关,并且在某些HLA II类等位基因与这些疾病之间可证明有很强的群体关联性。传统上,HLA易感位点的基因定位依赖于使用由同种抗血清、细胞分型试剂和组织相容性抗原的生化分析所定义的表型标志物。聚合酶链反应序列特异性寡核苷酸(PCR-SSO)分型通过分析相应的DNA序列,结合了定义最精细HLA特异性的能力以及研究大量正常和患病个体的可能性。本文综述了该技术在精确表征与类风湿性关节炎、I型糖尿病、乳糜泻和寻常型天疱疮等自身免疫性疾病易感性相关的MHC位点方面的应用。